NASTECH PHARMACEUTICAL CO INC (NSTK) is a publicly traded company in the Unknown sector. Across all available filings, 18 corporate insiders have executed 533 transactions totaling $5.4M, demonstrating a bearish sentiment with -$4.6M in net insider flow. The most recent transaction on May 14, 2008 involved a transaction of 10,000 shares valued at $12.6K.
No significant insider buying has been recorded for NSTK in the recent period.
No significant insider selling has been recorded for NSTK in the recent period.
Based on recent SEC filings, insider sentiment for NSTK is bearish with an Insider Alignment Score of 8/100 and a net flow of -$4.6M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at NASTECH PHARMACEUTICAL CO INC (NSTK) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 18 insiders are actively trading NSTK stock, having executed 533 transactions in the past 90 days. The most active insider is Paul H. Johnson (Executive), who has made 14 transactions totaling $1.9M.
Get notified when executives and directors at NSTK file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| May 14, 2008 | D. Cross Alexander | Executive | Award | 10,000 | $1.26 | $12.6K | |
| May 13, 2008 | R/fa Thaw Bruce | Executive | Purchase | 2,500 | $1.23 | $3.1K | |
| May 13, 2008 | R/fa Thaw Bruce | Executive | Purchase | 800 | $1.14 | $912 | |
| May 13, 2008 | R/fa Thaw Bruce | Executive | Purchase | 36,602 | $1.15 | $42.1K | |
| May 13, 2008 | R/fa Thaw Bruce | Executive | Purchase | 4,086 | $1.13 | $4.6K | |
| May 13, 2008 | R/fa Thaw Bruce | Executive | Purchase | 1,900 | $1.24 | $2.4K | |
| May 13, 2008 | R/fa Thaw Bruce | Executive | Purchase | 4,112 | $1.33 | $5.5K | |
| May 12, 2008 | T. Stanewick Gerald | Executive | Purchase | 10,000 | $1.14 | $11.4K | |
| Apr 1, 2008 | Brandt Gordon | Executive | Other | 1,201 | $2.00 | $2.4K | |
| Apr 1, 2008 | C. Quay Steven | Executive | Other | 3,500 | $2.00 | $7.0K | |
| Mar 19, 2008 | T. Stanewick Gerald | Executive | Purchase | 900 | $2.39 | $2.2K | |
| Mar 19, 2008 | T. Stanewick Gerald | Executive | Purchase | 4,100 | $2.40 | $9.8K | |
| Feb 12, 2008 | R. York Bruce | Executive | Award | 14,400 | $N/A | $0 | |
| Feb 12, 2008 | M. Duffy Timothy | Executive | Award | 14,400 | $N/A | $0 | |
| Dec 19, 2007 | Brandt Gordon | Executive | Award | 18,000 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 426 | $5.0M | 64.8% |
Exercise(M) | 28 | $1.9M | 24.2% |
Purchase(P) | 24 | $420.4K | 5.5% |
Payment(F) | 19 | $406.7K | 5.3% |
Award(A) | 32 | $12.6K | 0.2% |
Other(J) | 2 | $9.4K | 0.1% |
Gift(G) | 1 | $0 | 0.0% |
Disposition(D) | 1 | $0 | 0.0% |
Insider selling pressure at NASTECH PHARMACEUTICAL CO INC has increased, with 18 insiders executing 533 transactions across all time. Total sales of $5.0M significantly outpace purchases of $420.4K, resulting in a net outflow of $4.6M. This selling activity appears largely discretionary, which may warrant closer attention from investors.